109 results
Page 3 of 6
8-K
EX-99.1
ibuii3u 7s0ryx
9 Nov 22
Zentalis Pharmaceuticals Reports Third Quarter 2022 Financial Results and Operational Updates
7:04am
8-K
EX-99.2
b28jb p53ksxo5l4
9 Nov 22
Zentalis Pharmaceuticals Reports Third Quarter 2022 Financial Results and Operational Updates
7:04am
8-K
EX-99.2
nfdnh3v8q2ep
9 Aug 22
Zentalis Pharmaceuticals Reports Second Quarter 2022 Financial Results and Operational Update
12:00am
8-K
EX-99.1
wyfbts0p
9 Aug 22
Zentalis Pharmaceuticals Reports Second Quarter 2022 Financial Results and Operational Update
12:00am
8-K
EX-10.1
ubbdqao uwy
22 Jul 22
Departure of Directors or Certain Officers
4:15pm
424B5
siha4nliuze ke4g0z2l
16 May 22
Prospectus supplement for primary offering
5:17pm
8-K
EX-99.1
1h0h28u2j7t3
5 May 22
Zentalis Pharmaceuticals Reports First Quarter 2022 Financial Results and Operational Update
7:05am
424B5
cd3j6r68 r1tafa0p
27 Apr 22
Prospectus supplement for primary offering
4:15pm
8-K
EX-99.2
ndf646l
27 Apr 22
Zentalis Pharmaceuticals Announces $25 Million Equity Investment from Pfizer
4:09pm
8-K
EX-99.1
nnmpjo0v 9d
27 Apr 22
Zentalis Pharmaceuticals Announces $25 Million Equity Investment from Pfizer
4:09pm
8-K
ozrvz3qjrqhho6n7ximl
27 Apr 22
Zentalis Pharmaceuticals Announces $25 Million Equity Investment from Pfizer
4:09pm
8-K
EX-99.1
ymax 9guyq
11 Apr 22
Zentalis Pharmaceuticals Announces Overview of Clinical and Preclinical Data Presented at AACR
4:43pm
8-K
j66r4ng 1uqgu
8 Apr 22
Zentalis Pharmaceuticals Announces Positive Initial Clinical Data on ZN-c3, its Wee1 Inhibitor, in Patients with Advanced Ovarian Cancer at AACR
5:05pm
8-K
EX-99.1
yr9xwxsuw36
8 Apr 22
Zentalis Pharmaceuticals Announces Positive Initial Clinical Data on ZN-c3, its Wee1 Inhibitor, in Patients with Advanced Ovarian Cancer at AACR
5:05pm
8-K
EX-99.2
8z8gd 974vqddichg
8 Apr 22
Zentalis Pharmaceuticals Announces Positive Initial Clinical Data on ZN-c3, its Wee1 Inhibitor, in Patients with Advanced Ovarian Cancer at AACR
5:05pm
8-K
EX-99.1
9ubc h149phryclkf
24 Feb 22
Zentalis Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Update
7:05am